A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

INmune Bio's XPro shows promise in early AD despite missed endpoints. Click here to find out why I rate INMB stock is a Hold.

Scientists identify stress granules as the potential root cause of Alzheimer's disease. This new understanding may ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

Roughly 53 million people in the U.S. provide care to a family member such as a child with complex medical needs, an aging ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Sundowning is a common symptom in people with dementia, especially Alzheimer’s disease. It refers to a pattern where someone ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...